|
|
News Breaks | | | | November 8, 2012 | | 07:27 EDT |  | CBLI | Cleveland BioLabs reports Q3 EPS (30c) vs (8c) in Q3 of 2011
Reports Q3 R&D expenses down to about $4.8M. Revenues for Q3 decreased to approximately $0.2M from approximately $3.8M in Q3 of 2011, primarily due to decreases in research sponsored by the DoD, BARDA and a NY State/RPCI Sponsored Research Agreement. | |
|
News For CBLI From The Last 14 Days Check below for free stories on CBLI the last two weeks. |
|
|
| May 9, 2013 | | 07:50 EDT | | CBLI | Cleveland BioLabs reports Q1 EPS (22c), one estimate (17c)
Reports Q1 revenue $1.37M, one estimate $1.73M. | |
|
|
|
|
|
|
